Literature DB >> 11442834

The elimination of the yeast [PSI+] prion by guanidine hydrochloride is the result of Hsp104 inactivation.

P C Ferreira1, F Ness, S R Edwards, B S Cox, M F Tuite.   

Abstract

In the yeast Saccharomyces cerevisiae, Sup35p (eRF3), a subunit of the translation termination complex, can take up a prion-like, self-propagating conformation giving rise to the non-Mendelian [PSI+] determinant. The replication of [PSI+] prion seeds can be readily blocked by growth in the presence of low concentrations of guanidine hydrochloride (GdnHCl), leading to the generation of prion-free [psi-] cells. Here, we provide evidence that GdnHCl blocks seed replication in vivo by inactivation of the molecular chaperone Hsp104. Although growth in the presence of GdnHCl causes a modest increase in HSP104 expression (20-90%), this is not sufficient to explain prion curing. Rather, we show that GdnHCl inhibits two different Hsp104-dependent cellular processes, namely the acquisition of thermotolerance and the refolding of thermally denatured luciferase. The inhibitory effects of GdnHCl protein refolding are partially suppressed by elevating the endogenous cellular levels of Hsp104 using a constitutive promoter. The kinetics of GdnHCl-induced [PSI+] curing could be mimicked by co-expression of an ATPase-negative dominant HSP104 mutant in an otherwise wild-type [PSI+] strain. We suggest that GdnHCl inactivates the ATPase activity of Hsp104, leading to a block in the replication of [PSI+] seeds.

Entities:  

Mesh:

Substances:

Year:  2001        PMID: 11442834     DOI: 10.1046/j.1365-2958.2001.02478.x

Source DB:  PubMed          Journal:  Mol Microbiol        ISSN: 0950-382X            Impact factor:   3.501


  130 in total

1.  Cooperative kinetics of both Hsp104 ATPase domains and interdomain communication revealed by AAA sensor-1 mutants.

Authors:  Douglas A Hattendorf; Susan L Lindquist
Journal:  EMBO J       Date:  2002-01-15       Impact factor: 11.598

2.  Changes in the middle region of Sup35 profoundly alter the nature of epigenetic inheritance for the yeast prion [PSI+].

Authors:  Jia-Jia Liu; Neal Sondheimer; Susan L Lindquist
Journal:  Proc Natl Acad Sci U S A       Date:  2002-12-02       Impact factor: 11.205

Review 3.  Patterns of [PSI (+) ] aggregation allow insights into cellular organization of yeast prion aggregates.

Authors:  Jens Tyedmers
Journal:  Prion       Date:  2012-07-01       Impact factor: 3.931

Review 4.  Emergence and natural selection of drug-resistant prions.

Authors:  James Shorter
Journal:  Mol Biosyst       Date:  2010-04-27

5.  [PSI(+)] turns 50.

Authors:  Mick F Tuite; Gemma L Staniforth; Brian S Cox
Journal:  Prion       Date:  2015       Impact factor: 3.931

6.  The Paf1 complex subunit Rtf1 buffers cells against the toxic effects of [PSI+] and defects in Rkr1-dependent protein quality control in Saccharomyces cerevisiae.

Authors:  Kristin M Klucevsek; Mary A Braun; Karen M Arndt
Journal:  Genetics       Date:  2012-05-17       Impact factor: 4.562

7.  Generation and propagation of yeast prion [URE3] are elevated under electromagnetic field.

Authors:  Hui-Yong Lian; Kang-Wei Lin; Chuanjun Yang; Peng Cai
Journal:  Cell Stress Chaperones       Date:  2017-12-06       Impact factor: 3.667

8.  The mechanisms of [URE3] prion elimination demonstrate that large aggregates of Ure2p are dead-end products.

Authors:  Leslie Ripaud; Laurent Maillet; Christophe Cullin
Journal:  EMBO J       Date:  2003-10-01       Impact factor: 11.598

9.  Intrinsically Disordered Proteins Drive Emergence and Inheritance of Biological Traits.

Authors:  Sohini Chakrabortee; James S Byers; Sandra Jones; David M Garcia; Bhupinder Bhullar; Amelia Chang; Richard She; Laura Lee; Brayon Fremin; Susan Lindquist; Daniel F Jarosz
Journal:  Cell       Date:  2016-09-29       Impact factor: 41.582

10.  Conservation of a portion of the S. cerevisiae Ure2p prion domain that interacts with the full-length protein.

Authors:  Herman K Edskes; Reed B Wickner
Journal:  Proc Natl Acad Sci U S A       Date:  2002-08-12       Impact factor: 11.205

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.